If you believe that technology could be bridging the generation gap, think again. According to Deloitte’s first State of the Media report it’s as stark as ever.
read more
William Atkins
Tuesday, 29 January 2008 18:38
In their abstract, the researchers stated: “Evidence-based medicine is valuable to the extent that the evidence base is complete and unbiased. Selective publication of clinical trials — and the outcomes within those trials — can lead to unrealistic estimates of drug effectiveness and alter the apparent risk–benefit ratio.”
In the MedicalNewsToday.com article “Antidepressant Trials Are Selectively Reported, Study,” Turner stated: "Selective publication can lead doctors and patients to believe drugs are more effective than they really are, which can influence prescribing decisions."
Within the MNT.com article, it went on to say, “He was also careful to point out that just because there is over-reporting of positive results or there is a large number of negative studies, it does not mean that a particular drug is ineffective.”
Turner and his team are suggesting that the (perceived) selective reporting of the results of antidepressant drug within clinical drug trials could very well exaggerate their effectiveness.
They contend that these antidepressants are, indeed, more effective than placebos (sugar pills), but could give doctors and patients a false hope that they are going to be more effective than what will actually happen.
Think again. Most businesses only have PART of a DR plan - and this spells business disaster in the event of an IT disaster.
Download The Seven Sins of Disaster Recovery White Paper now and find out how you can prevent this happening to you.